Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. Mallinckrodt is the only provider of integrated systems for the delivery of Extracorporeal Photopheresis (ECP), THERAKOS™ Photopheresis Systems, which are used for treating a range of medical conditions, such as GvHD, CTCL, BOS and thoracic organ transplantation.
Part of our offer is formed by the Therakos ECP Institute – which partners with several European Centres of Excellence – ensuring we provide only the highest professional education and training to healthcare professionals – and with the aim of advancing knowledge in the field. By doing this, we can help to develop a more informed medical community which is better placed to deliver ECP Immunomodulation to patients.
Our Educational Offer
We are committed to offering an extensive range of educational initiatives, from face-to-face meetings to online content.
Discover more about each of our initiatives by clicking on the icons below.
If you are interested in any of our events or initiatives, please contact your Sales Representative directly.